STAT8m
U.K.’s cost-effectiveness agency says Alzheimer’s drug donanemab does not provide good value
For the second time in recent months, a U.K. agency said the limited benefits of a new Alzheimer’s drug do not justify its ...
STAT33m
No one wants to talk about Medicare policy
Health policy scholar Paul Ginsburg joins the "First Opinion Podcast" to discus Medicare policy and the election.
STAT34m
Q&A: Mark Cuban explains his beef with traditional PBMs — and why he thinks they’re destined to fail
Mark Cuban is a man on a mission — to disrupt the pharmaceutical industry.
STAT35m
What’s on the docket for Congress post-election: Chinese biotech, Medicare payments, ACA subsidies
Congress is facing a slew of expiring Medicare policies, and the end of Trump's tax cuts and Biden's extra ACA subsidies.
STAT35m
How to make sure opioid settlement money isn’t wasted
Opinion: More than $55 billion in opioid settlement money has flowed into state, county, and city coffers. Much of it is at ...
STAT1h
Study challenges finding that Black babies are more likely to survive under the care of Black physicians
New research calls into question the high-profile conclusion of the first major study to show a physician's race influences ...
STAT1h
Frustrated with Change Healthcare breach, senators propose removing limits on HIPAA fines
Linda Barbour thought she was more interested in the Change Healthcare cyberattack than most. Having worked as a medical ...